G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,055 | -42.4% | 99,344 | -0.4% | 0.00% | – |
| Q2 2023 | $248,286 | -25.6% | 99,713 | -19.9% | 0.00% | – |
| Q1 2023 | $333,792 | -47.8% | 124,549 | +5.8% | 0.00% | – |
| Q4 2022 | $639,421 | -45.0% | 117,757 | +26.7% | 0.00% | – |
| Q3 2022 | $1,162,000 | +155.9% | 92,975 | +1.2% | 0.00% | – |
| Q2 2022 | $454,000 | -84.7% | 91,891 | -76.5% | 0.00% | -100.0% |
| Q1 2022 | $2,968,000 | -28.6% | 390,586 | -4.0% | 0.00% | 0.0% |
| Q4 2021 | $4,155,000 | -23.7% | 406,967 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $5,448,000 | -40.9% | 405,911 | -3.4% | 0.00% | -50.0% |
| Q2 2021 | $9,222,000 | +2.0% | 420,372 | +11.9% | 0.00% | 0.0% |
| Q1 2021 | $9,038,000 | +25.6% | 375,687 | -6.1% | 0.00% | +100.0% |
| Q4 2020 | $7,196,000 | +49.8% | 400,013 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $4,804,000 | -54.1% | 415,943 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $10,477,000 | +127.2% | 431,805 | +3.2% | 0.00% | +100.0% |
| Q1 2020 | $4,611,000 | -58.4% | 418,494 | -0.3% | 0.00% | -50.0% |
| Q4 2019 | $11,097,000 | +20.6% | 419,863 | +3.9% | 0.00% | 0.0% |
| Q3 2019 | $9,203,000 | -0.8% | 404,010 | +33.6% | 0.00% | 0.0% |
| Q2 2019 | $9,273,000 | +92.5% | 302,452 | +4.2% | 0.00% | +100.0% |
| Q1 2019 | $4,817,000 | -10.7% | 290,152 | +3.0% | 0.00% | -50.0% |
| Q4 2018 | $5,393,000 | -60.7% | 281,680 | +7.4% | 0.00% | -33.3% |
| Q3 2018 | $13,715,000 | +30.1% | 262,320 | +8.2% | 0.00% | 0.0% |
| Q2 2018 | $10,538,000 | +81.8% | 242,495 | +55.0% | 0.00% | +50.0% |
| Q1 2018 | $5,796,000 | +250.6% | 156,437 | +87.8% | 0.00% | – |
| Q4 2017 | $1,653,000 | +2.1% | 83,288 | +28.0% | 0.00% | – |
| Q3 2017 | $1,619,000 | – | 65,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |